Table 7.
The median value of IgG antibody concentrations of all selected participants (n = 50) expressed in binding antibody units (BAU/mL) one month after the first and second dose of Pfizer’s SARS-CoV-2 vaccine with the distinction of the convalescent and non-previously SARS-CoV-2 infected participants.
| 1 Month after 1st Dose | 1 Month after 2nd Dose | p-Value | |||
|---|---|---|---|---|---|
| Median | IQR | Median | IQR | ||
| Convalescents | 2880.0 | 2364.78 | 2880.0 | 1033.7 | 0.8791 |
| Non-previously SARS-CoV-2 infected | 363.4 | 503.1 | 2880.0 | 1350.0 | 0.0005 |